SCHEMBL8795140

SCHEMBL8795140

NCc1ccc(OCCCCN2CCOCC2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.64
HRH3 Q9Y5N1 4/20 0.64
MAPK1 P28482 2/20 0.64
CYP1A2 P05177 1/20 0.64
CHRM2 P08172 1/20 0.64
CHRM1 P11229 1/20 0.64
HTR2A P28223 1/20 0.64
SCN1A P35498 1/20 0.64
HTR2B P41595 1/20 0.64
KCNH2 Q12809 1/20 0.64
SCN2A Q99250 1/20 0.64
SIGMAR1 Q99720 1/20 0.64
SCN3A Q9NY46 1/20 0.64
USP2 O75604 1/20 0.62
LMNA P02545 1/20 0.62
KDM4E B2RXH2 2/20 0.59
HTT P42858 1/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
LTA4H P09960 1/20 0.58
TSHR P16473 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8795711 0.95 HRH3 (0.70) ALDH1A1HRH3MAPK1CYP1A2CHRM2
SCHEMBL113404 0.91 LTA4H (0.69) ALDH1A1HRH3MAPK1CYP1A2CHRM2
SCHEMBL28126773 0.85 HRH3 (0.68) ALDH1A1HRH3MAPK1CYP1A2CHRM2
SCHEMBL22609310 0.85 LTA4H (0.65) ALDH1A1HRH3MAPK1CYP1A2CHRM2
SCHEMBL23963137 0.84 HRH3 (0.67) ALDH1A1HRH3MAPK1CYP1A2CHRM2
SCHEMBL16314572 0.84 ALDH1A1 (0.66) ALDH1A1HRH3MAPK1CYP1A2CHRM2
SCHEMBL29508030 0.82 ALDH1A1 (0.72) ALDH1A1HRH3MAPK1CYP1A2CHRM2
SCHEMBL16314629 0.82 HRH3 (0.68) ALDH1A1HRH3MAPK1CYP1A2CHRM2
SCHEMBL12835047 0.82 ALDH1A1 (0.72) ALDH1A1HRH3MAPK1CYP1A2CHRM2
SCHEMBL29508145 0.82 ALDH1A1 (0.82) ALDH1A1HRH3MAPK1CYP1A2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5698560-A TREATMENT OF CARDIOVASCULAR DISORDERS; ANTICOAGULANTS; CARDIOTONIC AGENTS; HYPOTENSIVE AGENTS; ARTERIOSCLEROSIS; CYCLIC GMP-SPECIFIC PHOSPHODIESTERASE INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 1997-12-16 US disclosed
EP-0683781-A4 NOVEL INHIBITORS OF ADENOSINE MONOPHOSPHATE DEAMINASE. GENSIA PHARMA (US) 1997-05-28 EP disclosed
EP-0758653-A1 IMIDAZOQUINAZOLINE DERIVATIVES KYOWA HAKKO KOGYO CO., LTD. (JP) 1997-02-19 EP disclosed
EP-0683781-A1 NOVEL INHIBITORS OF ADENOSINE MONOPHOSPHATE DEAMINASE GENSIA PHARMACEUTICALS, INC. (US) 1995-11-29 EP disclosed